Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Playing Defense In The House: PhRMA's Donut Hole Deal Garners Support From Democrats

This article was originally published in The Pink Sheet Daily

Executive Summary

Seventy House Democrats support PhRMA's discount proposal in lieu of phasing out the Part D coverage gap with funds from new rebates collected on drugs for dual-eligibles.

You may also be interested in...

PhRMA Health Reform Deal Is Not Binding On House, Rep. Waxman Declares

Waxman will keep pushing for Part D rebates to help fund closing the coverage gap, regardless of PhRMA's proposal for a different discount model. The good news for industry is that "dollars for donuts" remains the formula--and that even Waxman thinks industry will end up getting more than it gives.

Dollars For Donuts: PhRMA's $80 Bil. Coup In Health Care Reform

PhRMA's commitment to contribute $80 billion toward health systems savings over the next 10 years looks like an important tactical win for the brand name industry entering the critical phase of the health reform debate

House Health Reform Bill Increases Drug Rebates, Drops Part D Donut Hole

The House health care reform bill asks pharmaceutical manufacturers to pay their share of the cost of expanding health care coverage by paying higher rebates on more drugs


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts